Hedge Fund - Scopia Capital

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...

After all, activist hedge funds get most of their earnings from investing in companies and pushing them to provide more shareholder value.

Jeremy Mindich and Matthew Sirovich, the managers of Scopia Capital, have stepped up their activist efforts regarding Forest City Realty Trust Inc (NYSE:FCE.A).

Retrophin, Inc. (NASDAQ:RTRX) shares were trading as high as $37 last summer but like most small-cap biotech stocks lost a large chunk of its value since then.

According to HFR, hedge fund clients pulled more capital out of the hedge fund industry during the final quarter of 2015 than they invested, marking the first quarter with net capital outflows in four...

Matt Sirovich and Jeremy Mindich's Scopia Capital has increased its exposure to CONMED Corporation (NASDAQ:CNMD), as a recent filing with the US Securities and Exchange Commission showed.

It has been shown in the past that activist hedge funds can deliver above-average returns that are uncorrelated with broader market returns, but that has not been the case in the past year or so.

As a new filing with the US Securities and Exchange Commission showed, Matt Sirovich and Jeremy Mindich's Scopia Capital has unloaded its entire stake in Alere Inc (NYSE:ALR). The investor previously...

Matt Sirovich and Jeremy Mindich's Scopia Capital has disclosed a position in Insys Therapeutics Inc (NASDAQ:INSY) via a 13G filing with the US Securities and Exchange Commission.